• Submission

Journal of Pharmaceutical Research International

  • About
    • About the Journal
    • Submissions & Author Guideline
    • Articles in Press
    • Editorial Policy
    • Editorial Board Members
    • Reviewers
    • Propose a Special Issue
    • Reprints
    • Subscription
    • Membership
    • Publication Ethics and Malpractice Statement
    • Digital Archiving Policy
    • Contact
  • Archives
  • Indexing
  • Publication Charge
  • Books
  • Testimonials
Advanced Search
  1. Home
  2. Archives
  3. 2020 - Volume 32 [Issue 20]
  4. Original Research Article

Submit Manuscript


Subscription



  • Home Page
  • Author Guidelines
  • Editorial Board Member
  • Editorial Policy
  • Propose a Special Issue
  • Membership

Cross-Sectional Study of Prevalence of COVID-19 in Alkharj, Saudi Arabia

  • Nehad J. Ahmed

Journal of Pharmaceutical Research International, Page 184-188
DOI: 10.9734/jpri/2020/v32i2030740
Published: 28 August 2020

  • View Article
  • Download
  • Cite
  • References
  • Statistics
  • Share

Abstract


Aim: Forecasting the prevalence of the disease is important for health departments to strengthen surveillance systems and reallocate resources. The aim of this study is to assess the occurrence of COVID-19 in Alkharj, Saudi Arabia.


Methodology:  This is a cross-sectional study that included data about the occurrence of COVID-19 cases in Alkharj, Saudi Arabia between the 12th of July, 2020 till 5th of august, 2020. Data were extracted from Saudi Ministry of Health official site and also from Saudi Ministry of Health page on Facebook.


Results: The rate of cases in Alkharj were low in comparison with other cities. The number of population in Saudi Arabia was 34,871,847 in 2020. among of these people, More than 425,300 live in Alkharj. So Alkharj residents represent about 1.219 % of the total population in Saudi Arabia. COVID-19 cases in Alkharj represent only 0.576% of total cases in Saudi Arabia. In Alkharj, only 0.387 % of the population suffered from COVID-19 (out of 425,300 people there were 1646 COVID-19 patients)


Conclusion: This study showed a reduction in the number of COVID-19 cases but still it is essential to implement the preventive measures to reduce the number of COVID-19 cases.


Keywords:
  • Coronavirus
  • COVID-19
  • prevalence
  • Saudi Arabia.
  • Full Article - PDF
  • Review History

How to Cite

Ahmed, N. J. (2020). Cross-Sectional Study of Prevalence of COVID-19 in Alkharj, Saudi Arabia. Journal of Pharmaceutical Research International, 32(20), 184-188. https://doi.org/10.9734/jpri/2020/v32i2030740
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver

References

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet (London, England). 2020;395:497–506.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–513.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061- 1069.

Ge H, Wang X, Yuan X, Xiao G, Wang C, Deng T et al. The epidemiology and clinical information about COVID-19. Eur J Clin Microbiol Infect Dis. 2020;39(6):1011–1019.

International Committee on Taxonomy of Virus. Naming the 2019 Coronavirus. 2020. Retrieved 9 August 2020.

Available:https://talk.ictvonline.org/

Notice of the National Health Commission of the People’s Republic of China on revising the english name of novel coronavirus pneumonia. 2020. Retrieved 9 August 2020. Available:http://www.nhc.gov.cn/yzygj/s7653p/202002/33393aa53d984ccdb1053a52b6bef810.shtml.

World Health Organization. WHO Director-General’s Opening Remarks at the Media Briefing on COVID-19. 2020. Retrieved 9 August 2020.

Available:https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.

Ceylan Z. Estimation of COVID-19 prevalence in Italy, Spain, and France. Sci Total Environ. 2020;138817.

Pollán M, Pérez-Gómez B, Pastor-Barriuso R, Oteo J, Hernán MA, Pérez-Olmeda M et al. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study. The Lancet. 2020.

MOH News - MOH Reports First Case of Coronavirus Infection. (2020). Retrieved 9 August 2020.

Available:https://www.moh.gov.sa/en/Ministry/MediaCenter/News/Pages/News-2020-03-02-002.aspx

COVID 19 Dashboard: Saudi Arabia. (2020). Retrieved 9 August 2020.

Available:https://covid19.moh.gov.sa.

Saudi Ministry of Health. (2020). Retrieved 9 August 2020. Available:https://www.facebook.com/SaudiMOH.

Al-Tawfiq JA, Leonardi R, Fasoli G, Rigamonti D. Prevalence and fatality rates of COVID-19: What are the reasons for the wide variations worldwide?. Travel Med Infect Dis. 2020;35:101711.

Elhassan T, Gaafar A. Mathematical modeling of the COVID-19 prevalence in Saudi Arabia. medRxiv. 2020.

Coronavirus Disease 19 (COVID-19) Guidelines. (2020). Retrieved 13 August 2020. Available:https://www.moh.gov.sa/CCC/healthp/regulations/Documents/Coronavirus%20Disease%202019%20Guidelines%20v1.1..pdf

MOH News - COVID-19 Monitoring Committee Confirms that Recoveries Are More than New Cases. (2020). Retrieved 9 August 2020.

Available:https://www.moh.gov.sa/en/Ministry/MediaCenter/News/Pages/News-2020-05-13-003.aspx.
  • Abstract View: 535 times
    PDF Download: 291 times

Download Statistics

Downloads

Download data is not yet available.
  • Linkedin
  • Twitter
  • Facebook
  • Google Plus
  • Telegram
Make a Submission / Login
Information
  • For Readers
  • For Authors
  • For Librarians
Current Issue
  • Atom logo
  • RSS2 logo
  • RSS1 logo


© Copyright 2010-Till Date, Journal of Pharmaceutical Research International. All rights reserved.